SÜSS MicroTec (SMHN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Q1 2026 achieved record order intake of €149.3 million, up 69.5% year-over-year, breaking seasonal patterns and driven by strong demand in Advanced Backend and Photomask Solutions, especially from APAC and Chinese customers.
Revenue for Q1 2026 was €86.5 million, down 30.7% year-over-year, reflecting weak order intake from mid-2025 and marking the expected low point for the year.
Gross margin was 36.1%, within guidance but down 3.1 percentage points year-over-year; EBIT margin dropped to 4.3% due to reduced fixed cost coverage and higher R&D expenses.
Net profit fell 84.9% year-over-year to €2.5 million; EPS down to €0.13.
Order momentum remains strong into Q2, with flexible manufacturing capacity being ramped up.
Financial highlights
Order book at end of Q1 stood at €330.1 million, with most scheduled for delivery in 2026 and €300 million in tool orders.
Free cash flow increased to €23.2 million, a strong improvement year-over-year and quarter-over-quarter, supported by reduced working capital.
CapEx was €2.5 million, mainly for technical equipment in Germany and Taiwan, up 47.1% year-over-year.
Cash and cash equivalents rose to €120.9 million, up 22.5% from year-end 2025, driven by lower working capital.
Net cash position declined to €72.0 million, mainly due to lease obligations for new sites.
Outlook and guidance
Sales are expected to improve sequentially through 2026, with Q1 as the low point; full-year guidance confirmed: sales €425–485 million, gross margin 35–37%, EBIT margin 8–10%.
Q2 order intake is expected to be strong, potentially exceeding Q1's record level.
Product mix for 2026 is not expected to change significantly; visibility for 2026 has improved.
Management remains confident in achieving full-year revenue and profitability targets.
2026 is a transition year with temporary sales dip and lower EBIT margin due to fixed-cost undercoverage and higher R&D.
Latest events from SÜSS MicroTec
- Record 2025 sales and new product launches support ambitious 2030 growth targets.SMHN
German Select VII Conference15 Apr 2026 - Record 2025 sales and strategic investments set the stage for double-digit growth through 2030.SMHN
Investor presentation13 Apr 2026 - Record 2025 sales of €503.2M; 2026 outlook signals lower sales and margins amid higher R&D.SMHN
Q4 20252 Apr 2026 - Sales up 45.6%, EBIT margin at 15.6%, and guidance raised on strong order momentum.SMHN
Q2 20242 Feb 2026 - Record sales and margins in 2024 set a strong outlook for 2025 despite one-off costs.SMHN
Q4 202423 Dec 2025 - Record sales and EBIT growth offset by lower order intake and margin pressure, prompting guidance cuts.SMHN
Q2 202523 Nov 2025 - Sales targeted at €750–900 million and 43–45% margin by 2030, led by innovation and services.SMHN
CMD 202521 Nov 2025 - Q1 2025 sales up 31.8%, profit surged, but order intake fell amid rising macro risks.SMHN
Q1 202521 Nov 2025 - Margin pressure and lower net income prompt guidance cut, but Q4 order rebound expected.SMHN
Q3 202513 Nov 2025